The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library
Multiple myeloma - The Lancet
Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect
Cureus | Factors Explaining the Coincidence of Smoldering Multiple Myeloma and Primary Biliary Cholangitis: A Case Report
Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC
Cancers | Free Full-Text | Genome Instability in Multiple Myeloma: Facts and Factors | HTML
The t(4;14) translocation and IgH-MMSET hybrid RT-PCR assays. (A)... | Download Scientific Diagram
Biomedicines | Free Full-Text | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology
Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents | SpringerLink
Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels | Haematologica
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma | Leukemia
Frontiers | Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse
Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma | Haematologica
Dutcher bodies in IgA multiple myeloma | SpringerLink
Multiple Myeloma: Diagnosis and Treatment | AAFP
Multiple Myeloma | SpringerLink
The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library
All About Multiple Myeloma Test and Result Interpretations
Characterization and use of the novel human multiple myeloma cell line MC-B11/14 to study biological consequences of CRISPR-mediated loss of immunoglobulin A heavy chain - ScienceDirect
PDF) Oncology and Radiotherapy © Outcome of stage III-B IgA-Kappa FLC MM with t(4:14) karyotype: A Nigerian jehovah witness nine-year experience
Frontiers | Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma
Inter-patient heterogeneity in Multiple Myeloma. The two main... | Download Scientific Diagram
